Who We Are

BeyondPolio

BeyondPolio is a collaborative program and designated fund of the Jonas Salk Legacy Foundation, undertaken in conjunction with Spencer Trask & Co. The Jonas Salk Legacy Foundation is a charitable organization under Section 501(c)(3) of the Internal Revenue Code, and donations to support this program are deductible as charitable contributions to the extent permitted by law.

 

Sponsors

The Jonas Salk Legacy Foundation is dedicated to preserving and extending the contributions of one of society’s great scientists and humanitarians. It does so by helping to organize and make available the collection of Jonas Salk’s papers and historical artifacts, participating in and assisting with educational programs and projects, and exploring continued application of his scientific and philosophical vision towards solution of ongoing problems confronting humanity.  jonassalklegacyfoundation.org

Spencer Trask & Co. is a leading network of early-stage investors and business leaders that has provided financial and intellectual capital for some of the most influential ventures in technology and healthcare including Myriad Genetics, Ciena, Osiris Therapeutics, Health Dialog and others. Spencer Trask brings together angels, business leaders and entrepreneurs into a Value Creation Network where early-stage big ideas are transformed into great companies. spencertrask.com

 

Challenge Platform Provider 

InnoCentive is the open innovation and crowdsourcing pioneer that enables organizations to solve their key problems by connecting them to diverse sources of innovation including employees, customers, partners and the world’s largest problem solving marketplace. InnoCentive’s proven Challenge Driven Innovation methodology, community of millions of problem Solvers, and cloud-based technology platform combine to fundamentally transform the economics of innovation. Leading commercial, government and nonprofit organizations, such as Eli Lilly, Life Technologies, NASA, nature.com, Popular Science, Procter & Gamble, Roche, Rockefeller Foundation and The Economist, partner with InnoCentive to solve problems and innovate faster and more cost-effectively than ever before. For more information, visit innocentive.com.